Ted Abel co-authors study that finds epigenetics key to laying down spatial memories in mouse brain, providing possible new neurological medications.
News
Thanks to everyone for attending the Iowa Neuroscience Institute Science Thursday Demo...we had a great time! SCIENCE ACTIVITY: Awesome Brains The Iowa Neuroscience Institute will be demonstrating the awesomeness of brains! Stop by to see examples of animal and human brains, test your plasticity,...
Psychological Health Webinar: Outreach and Support to Military Families: Ethnic/Cultural Considerations April 27, 2017; 1-2:30 p.m. (ET) The U.S. military has a history steeped in cultural diversity. In 1948 President Harry Truman signed Executive Order 9981 that declared equal treatment and...
The American College of Neuropsychopharmacology (ACNP) is soliciting travel award applications for their annual meeting, to be held December 3-7, 2017, in Palm Springs, California.
Stephanie Alberico, a graduate student in the Narayanan Lab, recently won the University of Iowa's Graduate Research Excellence Award and was awarded third place at the Jakobsen Memorial Conference. Congratulations, Stephanie!
In UI research labs, undergrads learn life lessons and contribute to scientific discovery. Read more about neurobiology major Akanksha Chilukuri, who's researching the impact of preeclampsia on the brains and behavior of offspring.
Non-invasive stimulation of the cerebellum at a delta frequency normalizes brain activity in the frontal cortex of lab rats with schizophrenia-like thinking disorders, according to a first-of-its-kind new study from the University of Iowa Carver College of Medicine.
Cerebellar stimulation restores missing brain wave in rats and corrects timing deficit
Researchers report stimulating the cerebellum of rats with schizophrenia like cognitive problems helps to normalize brain activity in the frontal cortex and correct the rat’s ability to estimate the passage of time.
The cerebellum is most commonly associated with movement control, but work from Krystal Parker’s lab and others is gradually revealing a much more complex role in cognition that positions the cerebellum as a potential target for treating diseases that affect thinking, attention, and planning, such as schizophrenia.